T-Cell Immunotherapies Animation
Scientific Animation | Website & Social Media Assets
Anocca’s technology platform brings together biotechnologies and integrated software with the aim of developing TCR-modified T-cell (TCR-T) therapies. These therapies are being explored for their potential application in diverse cancer patients with hard-to-treat solid cancer types.
The immune system normally identifies and eliminates unhealthy cells, including cancer cells. However, cancer cells can sometimes evade this detection.
TCR-T therapy is being developed to address this challenge by reprogramming T-cells to potentially recognize cancer targets. This involves engineering T-cells to express a specific T-cell receptor (TCR) that aims to bind to a unique protein fragment on the surface of the cancer cell.
Anocca’s platform is designed to engineer human cells at scale for standardized, high-precision analysis. This process helps to map these protein fragment targets and generate therapeutic TCRs for further investigation.
Aimed at a general audience and industry stakeholders, the animation visually presents this advanced approach to TCR engineering with a futuristic aesthetic. The animation’s core content was adapted to create a visually engaging schematic, combining both 2D and 3D elements to illustrate the cellular interactions being investigated in this therapy.
This educational material is prominently featured on Annoca’s homepage and ‘Our Science’ page, further supported by looping banners and still imagery, to provide an initial impression for visitors to their corporate site. A short video excerpt from the animation was also used on their LinkedIn page to announce the new website launch, aiming to expand reach and maximize engagement.
Are you interested in seeing how our scientific animation can help you?
